Scilex Holding Company, a Sorrento Company, Announces That

SP-103 receives Fast Track Designation, which makes it eligible for some or all of the following: More frequent meetings or written communication with the...

Related Keywords

California ,United States ,San Diego ,Palo Alto ,Americans ,Jaisim Shah ,Dmitri Lissin ,Department Of The Institute For Health Metrics ,Drug Administration ,Vickers Vantage Corp ,Scilex Holding Company ,Nasdaq ,Vickers Venture Fund Vi Pte Ltd ,Sorrento Therapeutics Inc ,University Of Washington ,Vickers Venture Fund Vi Plan Pte Ltd ,Pivotal Trialc Le Ar Program ,Company Or Scilex ,Fast Track Designation ,Accelerated Approval ,Priority Review ,New Drug Application ,Holding Company ,Sorrento Therapeutics ,Chief Medical Officer ,Fast Track ,Chief Executive Officer ,Health Metrics ,Subjects With Moderate ,Severe Acute Lower Back Pain ,Text View ,United States Federal Food ,Cosmetic Act ,Vickers Vantage ,Vickers Venture Fund ,Pte Ltd ,Corticosteroid Lumbar Epidural Analgesia ,Full Text View ,Registration Statement ,Combined Company ,Securities Act ,Private Securities Litigation Reform Act ,Nasdaq Capital Market ,Nasdaq Srne ,Nc ,